Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.
Publication
, Journal Article
Apple, FS; Cullen, L; Felker, GM; Ginsburg, G; Morrow, D
Published in: Clin Chem
January 2017
Duke Scholars
Published In
Clin Chem
DOI
EISSN
1530-8561
Publication Date
January 2017
Volume
63
Issue
1
Start / End Page
1 / 4
Location
England
Related Subject Headings
- Proteomics
- Male
- Humans
- Genomics
- General Clinical Medicine
- Female
- Cardiovascular Diseases
- Biomarkers
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Apple, F. S., Cullen, L., Felker, G. M., Ginsburg, G., & Morrow, D. (2017). Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem, 63(1), 1–4. https://doi.org/10.1373/clinchem.2016.263350
Apple, Fred S., Louise Cullen, G Michael Felker, Geoffrey Ginsburg, and David Morrow. “Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.” Clin Chem 63, no. 1 (January 2017): 1–4. https://doi.org/10.1373/clinchem.2016.263350.
Apple FS, Cullen L, Felker GM, Ginsburg G, Morrow D. Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem. 2017 Jan;63(1):1–4.
Apple, Fred S., et al. “Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics.” Clin Chem, vol. 63, no. 1, Jan. 2017, pp. 1–4. Pubmed, doi:10.1373/clinchem.2016.263350.
Apple FS, Cullen L, Felker GM, Ginsburg G, Morrow D. Cardiovascular Disease: Impact of Biomarkers, Proteomics, and Genomics. Clin Chem. 2017 Jan;63(1):1–4.
Published In
Clin Chem
DOI
EISSN
1530-8561
Publication Date
January 2017
Volume
63
Issue
1
Start / End Page
1 / 4
Location
England
Related Subject Headings
- Proteomics
- Male
- Humans
- Genomics
- General Clinical Medicine
- Female
- Cardiovascular Diseases
- Biomarkers
- 3205 Medical biochemistry and metabolomics
- 3202 Clinical sciences